One-pot synthesis of pyrrolo[1,2-a]quinoxaline and pyrrolo[1,2-a]pyrazine derivatives via the three-component reaction of 1,2-diamines, ethyl pyruvate and α-bromo ketones

[1]  L. Moradi,et al.  One-pot multicomponent synthesis of novel tricyclic pyrrolo[2,1-c][1,4]benzoxazines , 2014 .

[2]  L. Moradi,et al.  One-pot synthesis of pyrrolo[1,2-a]pyrazines via three component reaction of ethylenediamine, acetylenic esters and nitrostyrene derivatives , 2013 .

[3]  L. Moradi,et al.  A one-pot catalyst-free synthesis of functionalized pyrrolo[1,2-a]quinoxaline derivatives from benzene-1,2-diamine, acetylenedicarboxylates and ethyl bromopyruvate , 2013, Beilstein journal of organic chemistry.

[4]  A. Furlan,et al.  'Click' synthesis of a triazole-based inhibitor of Met functions in cancer cells. , 2012, Bioorganic & medicinal chemistry letters.

[5]  Vipender Singh,et al.  AuI-Catalyzed Direct Hydroamination/Hydroarylation and Double Hydroamination of Terminal Alkynes , 2010 .

[6]  N. T. Patil,et al.  Platinum-catalyzed formal Markownikoff's hydroamination/hydroarylation cascade of terminal alkynes assisted by tethered hydroxyl groups. , 2009, The Journal of organic chemistry.

[7]  I. Yavari,et al.  Synthesis of pyrrolo[2,1-a]isoquinolines from activated acetylenes, benzoylnitromethanes, and isoquinoline , 2009 .

[8]  C. Bolm,et al.  Iron-catalysed carbon-heteroatom and heteroatom-heteroatom bond forming processes. , 2008, Chemical Society reviews.

[9]  Rob Leurs,et al.  Fragment based design of new H4 receptor-ligands with anti-inflammatory properties in vivo. , 2008, Journal of medicinal chemistry.

[10]  Chae S. Yi,et al.  Scope and mechanistic study of the ruthenium-catalyzed ortho-C-H bond activation and cyclization reactions of arylamines with terminal alkynes. , 2005, Journal of the American Chemical Society.

[11]  N. Monteiro,et al.  Pd‐Assisted Multicomponent Synthesis of Heterocycles , 2003 .

[12]  L. Weber.  Multi-component reactions and evolutionary chemistry. , 2002, Drug discovery today.

[13]  B. Insuasty,et al.  A versatile synthesis of 4,5‐dihydropyrrolo[1,2‐a]quinoxalines , 2001 .

[14]  R. David,et al.  Changing therapeutic paradigms in glaucoma management. , 1998, Expert opinion on investigational drugs.

[15]  G. Adams,et al.  Heterocyclic mono-N-oxides with potential applications as bioreductive anti-tumour drugs: Part 1. 8-Alkylamino-substituted phenylimidazo [1,2-a] quinoxalines. , 1993, Anti-cancer drug design.

[16]  A. Furlan,et al.  Identification of new aminoacid amides containing the imidazo[2,1-b]benzothiazol-2-ylphenyl moiety as inhibitors of tumorigenesis by oncogenic Met signaling. , 2012, European journal of medicinal chemistry.